To explore the role of preoperative EGD in metabolic-bariatric surgery by assessing patient demographics, EGD findings, and the correlation with gastric pathologies in surgical specimens, highlighting the significance of these findings for surgical outcomes.
Key Findings:
36.9% of patients undergoing MBS had preoperative EGD.
EGD findings included H. pylori in 8.16% and gastric intestinal metaplasia in 2.64% of patients.
135 patients had clinically significant gastric pathology in surgical specimens.
Interpretation:
Preoperative EGD may reveal significant gastric pathologies that could influence surgical planning, although its routine use in asymptomatic patients remains debated, necessitating further discussion on best practices.
Limitations:
Retrospective design may introduce selection bias, potentially affecting the generalizability of the findings.
Lack of a standardized protocol for EGD prior to MBS may lead to inconsistencies in practice.
Conclusion:
While preoperative EGD can identify significant findings in some patients, its universal application is not recommended; an individualized approach is preferred, warranting further research to optimize patient outcomes.
by Baila Elkin, Joseph El-Dahdah, Qijun Yang, Yueqi Wu, John McMichael, Michelle Kang Kim, Ricard Corcelles Codina, Carlos Roberto Simons Linares, Carol Rouphael
